Skip to content
healthcare.dev

B07 DPRSN ANTITOX

NDC 63479-0207, ADRENALINUM, AETHUSA CYNAPIUM, AGNUS CASTUS, ALFALFA, ARGENTUM NITRICUM, AURUM METALLICUM, AVENA SATIVA, CERATOSTIGMA WILLMOTTIANUM FLOWER, CHERRY PLUM FLOWER, DAMIANA, EUROPEAN ASPEN FLOWER, EUROPEAN HORNBEAM FLOWER, GORSE FLOWER, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, MANDRAGORA OFFICINARUM, NATRUM MURIATICUM, PASSIFLORA INCARNATA, ROSA CANINA FLOWER, SEPIA, SWEET CHESTNUT FLOWER, THYROIDINUM, WILD MUSTARD FLOWER, solution/ drops, from Apex Energetics Inc..

Product NDC
63479-0207
Status
Listed
Labeler
Apex Energetics Inc.
Dosage form
SOLUTION/ DROPS
Route
SUBLINGUAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63479-0207 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CHASTE TREE2 [hp_X]/mL
  • AVENA SATIVA FLOWERING TOP1 [hp_X]/mL
  • CARPINUS BETULUS FLOWER15 [hp_X]/mL
  • CASTANEA SATIVA FLOWER15 [hp_X]/mL
  • THYROID, UNSPECIFIED6 [hp_X]/mL
  • TURNERA DIFFUSA LEAFY TWIG1 [hp_X]/mL
  • POPULUS TREMULA FLOWERING TOP30 [hp_X]/mL
  • ULEX EUROPAEUS FLOWER30 [hp_X]/mL
  • SODIUM CHLORIDE30 [hp_X]/mL
  • PASSIFLORA INCARNATA FLOWERING TOP1 [hp_X]/mL
  • SEPIA OFFICINALIS JUICE30 [hp_X]/mL
  • GOLD30 [hp_X]/mL
  • EPINEPHRINE6 [hp_X]/mL
  • PRUNUS CERASIFERA FLOWER15 [hp_X]/mL
  • HYPERICUM PERFORATUM3 [hp_X]/mL
  • POTASSIUM PHOSPHATE, DIBASIC30 [hp_X]/mL
  • MANDRAGORA OFFICINARUM ROOT30 [hp_X]/mL
  • LYCOPODIUM CLAVATUM SPORE60 [hp_X]/mL
  • ROSA CANINA FLOWER15 [hp_X]/mL
  • SINAPIS ARVENSIS FLOWERING/FRUITING TOP15 [hp_X]/mL
  • AETHUSA CYNAPIUM30 [hp_X]/mL
  • ALFALFA1 [hp_X]/mL
  • SILVER NITRATE30 [hp_X]/mL
  • CERATOSTIGMA WILLMOTTIANUM FLOWER30 [hp_X]/mL

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Catecholamine [EPC]; Catecholamines [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]; Standardized Chemical Allergen [EPC]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
63479-0207-16347902070130 mL in 1 BOTTLE, GLASS (63479-0207-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 63479-0207 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63479-0207 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63479-0207. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.